Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01418248 · ClinicalTrials.gov registry record
Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 108
- Enrollment target
NCT01418248: Completed study, sponsored by Mayo Clinic.
NCT01418248 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 108 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01418248 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
Heart Failure with Preserved Ejection Fraction (HFpEF) and Pulmonary Hypertension (PH) can be diagnosed noninvasively by Exercise Echocardiography (ExE) and Cardiopulmonary Exercise Testing (CPX) as compared with gold standard invasive hemodynamic assessment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01418248
The ClinicalTrials.gov registry entry for NCT01418248 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01418248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01418248 about?
NCT01418248 is a clinical study titled "Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease". Heart Failure with Preserved Ejection Fraction (HFpEF) and Pulmonary Hypertension (PH) can be diagnosed noninvasively by Exercise Echocardiography (ExE) and Cardiopulmonary Exercise Testing (CPX) as compared with gold standard invasive hemodynamic assessment.
What is the current status of trial NCT01418248?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2011-08. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT01418248?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.